Clinical feasibility and oncological safety of targeted axillary dissection after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: A prospective registry study

被引:1
|
作者
Wu, S. [1 ]
Li, J. [1 ]
Wang, Y. [2 ]
Liu, G. [1 ]
机构
[1] Fudan Univ Shanghai Canc Ctr, Breast Surg Dept, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ Sch Med, Ruijin Hosp, Dept Radiat Oncol, Shanghai, Peoples R China
关键词
D O I
10.1016/j.annonc.2022.07.229
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
194P
引用
收藏
页码:S624 / S625
页数:2
相关论文
共 50 条
  • [21] Targeted Axillary Dissection for Patients Who Convert to Clinically Node Negative After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer
    Kandice Ludwig
    Amanda L. Kong
    Current Breast Cancer Reports, 2020, 12 : 391 - 397
  • [22] Use of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytology proven axillary node-positive breast cancer at diagnosis
    Choi, H. J.
    Jung, S. M.
    Ryu, J. M.
    Kim, I.
    Nam, S. J.
    Kim, S. W.
    Yu, J.
    Lee, S. K.
    Lee, J. E.
    ANNALS OF ONCOLOGY, 2018, 29
  • [23] Targeted Axillary Dissection for Patients Who Convert to Clinically Node Negative After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer
    Ludwig, Kandice
    Kong, Amanda L.
    CURRENT BREAST CANCER REPORTS, 2020, 12 (04) : 391 - 397
  • [24] Targeted axillary dissection after neoadjuvant systemic therapy in patients with node-positive breast cancer
    Kanesalingam, Kavitha
    Sriram, Nina
    Heilat, Ghaith
    Ng, E-Ern
    Meybodi, Farid
    Elder, Elisabeth
    Brennan, Meagan
    French, James
    ANZ JOURNAL OF SURGERY, 2020, 90 (03) : 332 - 338
  • [25] Targeted axillary dissection reduces residual nodal disease in clinically node-positive breast cancer after neoadjuvant chemotherapy
    Cabioglu, Neslihan
    Karanlik, Hasan
    Yilmaz, Ravza
    Emiroglu, Selman
    Tukenmez, Mustafa
    Bademler, Sueleyman
    Simsek, Duygu Has
    Kantarci, Tarik Recep
    Yirgin, Inci Kizildag
    Bayram, Aysel
    Dursun, Memduh
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [26] Incorporation of Repeated Core Needle Biopsy and Targeted Fine Needle Aspiration to Optimize Axillary Surgery After Neoadjuvant Chemotherapy in Node-positive Breast Cancer: A Prospective Feasibility Study
    Wu, Siyu
    Li, Jianwei
    Zhang, Ying
    Hu, Na
    Liu, Guangyu
    CANCER RESEARCH, 2023, 83 (05)
  • [27] Is Axillary Radiation not Inferior to Axillary Dissection for Sentinel Lymph Node-Positive Breast Cancer After Neoadjuvant Chemotherapy?
    Khan, Tahsin M.
    Rossi, Alexander J.
    Suman, Vera
    Haffty, Bruce
    Hernandez, Jonathan M.
    Boughey, Judy C.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (03) : 1526 - 1527
  • [28] Feasibility and Prognostic Effect of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Cytology-Proven, Node-Positive Breast Cancer
    Park, Sungmin
    Lee, Jeong Eon
    Paik, Hyun-June
    Ryu, Jai Min
    Bae, Soo Youn
    Lee, Se Kyung
    Kim, Seok Won
    Nam, Seok Jin
    CLINICAL BREAST CANCER, 2017, 17 (01) : E19 - E29
  • [29] Role of Primary Chemotherapy in Women with Biopsy-proven Lymph Node-positive Breast Cancer
    Germanou, S.
    Rush, H.
    Chowdhury, M. H. R.
    Bhaludin, B.
    Karapanagiotou, E.
    Sandri, I.
    Mansi, J.
    CLINICAL ONCOLOGY, 2019, 31 (07) : E108 - E109
  • [30] Is Axillary Radiation not Inferior to Axillary Dissection for Sentinel Lymph Node-Positive Breast Cancer After Neoadjuvant Chemotherapy?
    Tahsin M. Khan
    Alexander J. Rossi
    Vera Suman
    Bruce Haffty
    Jonathan M. Hernandez
    Judy C. Boughey
    Annals of Surgical Oncology, 2022, 29 : 1526 - 1527